Sun Pharma Advanced Research shines on plan to file new drug application for opthalmic solution in Q2 FY’14

26 Mar 2013 Evaluate

Sun Pharma Advanced Research Company is currently trading at Rs. 107.95, up by 1.60 points or 1.50% from its previous closing of Rs. 106.35 on the BSE.

The scrip opened at Rs. 107.50 and has touched a high and low of Rs. 108.80 and Rs. 106.80 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 145.80 on 04-Jan-2013 and a 52 week low of Rs. 65.68 on 15-Jun-2012.

The current market cap of the company is Rs. 2,554.00 crore.

The promoters holding in the company stood at 67.13% while Institutions and Non-Institutions held 8.28% and 24.59% respectively.

Sun Pharma Advanced Research Company (SPARC) has planned to file a new drug application for Latanoprost BAKfree opthalmic solution to be used for treating glaucoma. The company is planning to file the application in the second quarter of the next financial year. The company has completed pre-NDA (new drug application) meeting with US Food and Drug Administration (USFDA) for Latanoprost ‘BAK Free’ ophthalmic solution and the NDA.

Besides, SPARC has already managed to raise funds in the tune of Rs 200 crore, which will help the company in continuing to fund its investments for various studies going through.

Further, the company has made significant progress in its various key programmes that have surpassed critical milestones. The company has filed two new drug applications (NDAs) one for Levetiracetam ER 1000mg and 1500mg tablets for treatment of epilepsy and the other for Venlafaxine ER 300 mg tablets for treatment of depression.

SPARC was formed in 2007, when Sun Pharmaceutical Industries separated out its active projects in drug discovery and innovation into the new company. SPARC undertakes projects in research and technology for new chemical entities (NCE’s) or new molecules, and novel drug delivery systems. The company’s core focus is innovation and new product development for global markets.

Sun Pharma Adv. Res Share Price

134.05 -1.55 (-1.14%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 520.25
CMS Info Systems 344.60
Sagility 52.62
Smartworks Coworking 468.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×